SLC6A3 and Parkinson disease: Several DAT ligands have been successfully used as methods for evaluating neuronal loss, for PD diagnosis.11,13–19 For this reason, DAT ligands have become well-established markers that are useful for evaluating changes in presynaptic DAT sites in vivo and in vitro.